High prevalence of fluoroquinolone-resistant UTI among US emergency department patients diagnosed with urinary tract infection, 2018-2020.

Authors:
Faine BA; Rech MA; Vakkalanka P; Gross A; Brown C and 18 more

Journal:
Acad Emerg Med

Publication Year: 2022

DOI:
10.1111/acem.14545

PMCID:
PMC9543902

PMID:
35652493

Journal Information

Full Title: Acad Emerg Med

Abbreviation: Acad Emerg Med

Country: Unknown

Publisher: Unknown

Language: N/A

Publication Details

Subject Category: Emergency Medicine

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Transparency Score
3/6
50.0% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Data Sharing
Code Sharing
Evidence found in paper:

"CONFLICT OF INTEREST The following authors report no conflict of interest: A.G., C.B., A.Z., S.R., J.D., L.N., B.P., P.S., A.M., A.B., and G.K. The following authors received funding by Spero Therapeutics provided unrestricted research grant via its Investigator initiated research program, B.F., M.R., P.V., S.H., G.S., D.Z., G.H., M.C., C.T., M.J., T.F., and D.T. REDCap database was supported by the National Center for Advancing Translational Sciences of the National Institutes of Health under Award Number UL1TR002537. CB was partially funded by a research grant from the Mayo Midwest Pharmacy Research Committee."

Evidence found in paper:

"FUNDING INFORMATION Some of the work was supported by Spero Therapeutics Investigator Initiated Research Program."

Protocol Registration
Open Access
Paper is freely available to read
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025